HBI Spotlight

 

Artemis founder speaks out after damning documentary on primetime TV

A primetime ‘exposé’ of how private equity operates in the German ophthalmology market had some of its largest operators in its crosshairs last week. We talk to the founder of Artemis Augenkliniken, who was interviewed on camera, and a specialist healthcare lawyer, for their take on hitting the headlines for the wrong reasons.
April 14, 2022

€4bn Inovie looking for majority shareholder

French lab group Inovie is looking for a new majority stakeholder off a €4bn+ enterprise value, HBI hears. Inovie is currently working with financial advisers to determine interest from potential buyers.
April 7, 2022

“For sale” Fresenius creates new $2.4bn business

As Germany-based healthcare conglomerate Fresenius looks to simplify the group's structure, selling off non-core parts of a business which currently spans hospitals, dialysis, pharma, rehabilitation and more, it is building a $2.4bn new business partnership in the US. We speak to an EU-based source familiar with Fresenius to put this all in context.
March 24, 2022

Will record results for Synlab precipitate Cinven sale?

Almost a year after its IPO, lab giant Synlab has posted strong FY21 results bolstered by Covid, but not, it says, dependant on it. Management say extra cash will be used as a springboard for growth. Could it also lead to private equity majority shareholder Cinven selling its remaining interest?
March 17, 2022

Ramsay makes eye-watering bid for GHP

Ramsay Santé, the European branch of multinational hospital giant Ramsay Healthcare, has made a bid for listed Swedish specialty care provider GHP Specialty Care.
March 10, 2022

UK self-pay “almost doubles” to a potential 15m

The self-pay market in the UK is growing much faster than other parts of the private sector. Justin Ash, CEO of the UK’s second largest for-profit hospital group, Spire Healthcare, tells us it almost doubled to 15m people in the past two years, and will only continue to grow in the face of the NHS backlog.
March 3, 2022

Fresenius break up debate goes public

Giant health care conglomerate Fresenius SE has publicly floated the possibility of bringing minority equity shareholders in at the level of divisions such as Vamed or Helios in its 2021 results announcement. It has even suggested it could sell its controlling stake in dialysis arm Fresenius Medical Care. But at least one investment bank is publicly stating this doesn't go far enough.
February 25, 2022

Who is building broad outpatient businesses in Europe?

A wide range of outpatient specialities can be linked to a diagnostics and/or primary care back bone, building a complete ambulatory ecosystem linked by telehealth. Thanks to employers paying, this is a reality in Finland with Terveystalo and in Poland with Lux-Med and Medicover. Similar hub and spoke models are also the norm in the United Arab Emirates. But can it be done elsewhere and who is doing it? We name the highly ambitious operators and their platforms across the main European countries.
February 17, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us